Financhill
Back

Pliant Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight buying pressure.

Pliant Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 12.82 Buy
20-day SMA: 11.9 Buy
50-day SMA: 12.24 Buy
200-day SMA: 14.54 Sell
8-day EMA: 12.73 Buy
20-day EMA: 12.26 Buy
50-day EMA: 12.34 Buy
200-day EMA: 14.6 Sell

Pliant Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.35 Buy
Relative Strength Index (14 RSI): 62.94 Buy
Chaikin Money Flow: 260351 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.67 - 12.73) Buy
Bollinger Bands (100): (11.58 - 14.72) Buy

Pliant Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Pliant Therapeutics Stock

Is Pliant Therapeutics Stock a Buy?

PLRX Technical Analysis vs Fundamental Analysis

Buy
54
Pliant Therapeutics (PLRX) is a Buy

Is Pliant Therapeutics a Buy or a Sell?

Pliant Therapeutics Stock Info

Market Cap:
802.18M
Price in USD:
13.30
Share Volume:
629.99K

Pliant Therapeutics 52-Week Range

52-Week High:
20.23
52-Week Low:
10.29
Buy
54
Pliant Therapeutics (PLRX) is a Buy

Pliant Therapeutics Share Price Forecast

Is Pliant Therapeutics Stock a Buy?

  • Pliant Therapeutics share price is 13.30 while PLRX 8-day exponential moving average is 12.73, which is a Buy signal.
  • The stock price of PLRX is 13.30 while Pliant Therapeutics 20-day EMA is 12.26, which makes it a Buy.
  • Pliant Therapeutics 50-day exponential moving average is 12.34 while PLRX share price is 13.30, making it a Buy technically.
  • PLRX stock price is 13.30 and Pliant Therapeutics 200-day simple moving average is 14.60, creating a Sell signal.

Fundamental Analysis of Pliant Therapeutics

Is Pliant Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.27 per share.

Technical Analysis of Pliant Therapeutics

Should I short Pliant Therapeutics stock?

* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.